Hangzhou Regenovo Biotechnology., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hangzhou Regenovo Biotechnology., Ltd. - overview
Established
2013
Location
Hangzhou, Zhejiang, China
Primary Industry
Biotechnology
About
Established in 2013 and based in Hangzhou, China, Hangzhou Regenovo Biotechnology. , Ltd. is a biotechnology company that focuses on the research and development of 3D printing technology in the biomedical field, which won the Vice Chairman Unit of China 3D Printing Technology Industry Alliance, Vice Chairman Unit of Zhejiang Translational Medicine Association, and so on. It has established partnerships with Peking University, OLAY, Fan Beauty Secret, etc.
In September 2020, Hangzhou Regenovo Biotechnology. , Ltd. raised strategic investment from new investors Proya and Zheshang Venture Capital. The company is committed to providing systematic products and services for scientific research, drug development, regenerative medicine, and personalized medical research and clinical applications.
The business includes biological 3D printing systematic equipment, biomaterials and bio-inks, drug development tools for pharmaceutical companies, and treatment methods for patients with tissue and organ defects.
Current Investors
Share Capital, Five Bulls Fund, First Seafront Fund
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Medical Supplies, Biomaterials
Website
www.regenovo.com
Verticals
3D Printing, HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.